Merck KGaA will buy Silence Therapeutics and its siRNA pipeline for $1.3B

October 19, 2026 09:57 AM EDT DealsCell/Gene Tx Mer­ck KGaA to buy Si­lence Ther­a­peu­tics and its siR­NA pipeline for $1.3B Drew Armstrong Executive Editor Ger­many’s Mer­ck KGaA agreed to buy UK drug de­vel­op­er Si­lence Ther­a­peu­tics for $1.3 bil­lion, build­ing out its work in rare and spe­cial­ty dis­eases us­ing ge­net­ic … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER